Ocular Therapeutix Price to Sales Ratio 2013-2025 | OCUL

Historical PS ratio values for Ocular Therapeutix (OCUL) over the last 10 years. The current P/S ratio for Ocular Therapeutix as of December 04, 2025 is .
Ocular Therapeutix P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-12-04 12.43 37.88
2025-09-30 11.69 $0.33 35.62
2025-06-30 9.28 $0.34 27.18
2025-03-31 7.33 $0.36 20.21
2024-12-31 8.54 $0.41 20.76
2024-09-30 8.70 $0.48 18.26
2024-06-30 6.84 $0.56 12.19
2024-03-31 9.10 $0.66 13.86
2023-12-31 4.46 $0.72 6.22
2023-09-30 3.14 $0.71 4.39
2023-06-30 5.16 $0.69 7.44
2023-03-31 5.27 $0.65 8.14
2022-12-31 2.81 $0.63 4.43
2022-09-30 4.15 $0.61 6.76
2022-06-30 4.02 $0.60 6.69
2022-03-31 4.95 $0.59 8.33
2021-12-31 6.97 $0.52 13.43
2021-09-30 10.00 $0.49 20.40
2021-06-30 14.18 $0.43 32.72
2021-03-31 16.41 $0.32 51.62
2020-12-31 20.70 $0.28 72.88
2020-09-30 7.61 $0.21 35.74
2020-06-30 8.33 $0.14 58.18
2020-03-31 4.95 $0.13 37.79
2019-12-31 3.95 $0.09 43.01
2019-09-30 3.04 $0.06 55.04
2019-06-30 4.40 $0.05 84.17
2019-03-31 3.97 $0.05 72.99
2018-12-31 3.98 $0.05 75.06
2018-09-30 6.88 $0.06 121.33
2018-06-30 6.75 $0.06 109.01
2018-03-31 6.51 $0.06 108.97
2017-12-31 4.45 $0.07 66.27
2017-09-30 6.18 $0.07 87.23
2017-06-30 9.27 $0.07 128.65
2017-03-31 9.28 $0.07 124.11
2016-12-31 8.37 $0.08 110.00
2016-09-30 6.87 $0.07 92.52
2016-06-30 4.95 $0.07 68.35
2016-03-31 9.66 $0.08 128.24
2015-12-31 9.37 $0.08 122.06
2015-09-30 14.06 $0.11 133.38
2015-06-30 21.03 $0.10 215.73
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.442B $0.064B
Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular Therapeutix, Inc. is headquartered in Bedford, Massachusetts.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.883B 33.00
Zoetis (ZTS) United States $54.016B 19.33
Takeda Pharmaceutical (TAK) Japan $45.534B 9.29
Daiichi Sankyo, - (DSNKY) Japan $43.286B 21.56
BeOne Medicines - (ONC) Switzerland $40.049B 196.43
Sandoz Group AG (SDZNY) Switzerland $31.548B 0.00
United Therapeutics (UTHR) United States $20.709B 18.23
Merck (MKKGY) Germany $18.152B 11.19
Neurocrine Biosciences (NBIX) United States $15.151B 36.35
Shionogi (SGIOY) Japan $14.326B 13.16
Summit Therapeutics (SMMT) United States $14.166B 0.00
Ionis Pharmaceuticals (IONS) United States $13.256B 0.00
Madrigal Pharmaceuticals (MDGL) United States $13.170B 0.00
IPSEN (IPSEY) France $12.079B 0.00
Orion OYJ (ORINY) Finland $9.922B 28.35
Corcept Therapeutics (CORT) United States $8.801B 95.08
Eisai (ESAIY) $8.732B 0.00
Stevanato Group S.p.A (STVN) Italy $7.074B 39.59
Ono Pharmaceutical (OPHLF) Japan $6.238B 18.97
Grifols, S.A (GRFS) Spain $6.037B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.560B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.458B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.028B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.908B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.829B 18.18
Hypermarcas (HYPMY) Brazil $3.123B 21.43
Dyne Therapeutics (DYN) United States $2.869B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.839B 9.06
Soleno Therapeutics (SLNO) United States $2.724B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.086B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.966B 23.30
Guardian Pharmacy Services (GRDN) United States $1.853B 35.68
BioCryst Pharmaceuticals (BCRX) United States $1.653B 98.12
Harrow (HROW) United States $1.649B 101.18
Amylyx Pharmaceuticals (AMLX) United States $1.561B 0.00
Collegium Pharmaceutical (COLL) United States $1.513B 7.49
Oruka Therapeutics (ORKA) United States $1.433B 0.00
Ardelyx (ARDX) United States $1.402B 0.00
Relay Therapeutics (RLAY) United States $1.357B 0.00
Savara (SVRA) United States $1.282B 0.00
Enliven Therapeutics (ELVN) United States $1.246B 0.00
Xencor (XNCR) United States $1.236B 0.00
Nektar Therapeutics (NKTR) United States $1.162B 0.00
Evotec AG (EVO) Germany $1.133B 0.00
Xeris Biopharma Holdings (XERS) United States $1.117B 0.00
Cronos Group (CRON) Canada $0.961B 0.00
Theravance Biopharma (TBPH) United States $0.957B 40.19
ARS Pharmaceuticals (SPRY) United States $0.944B 0.00
Esperion Therapeutics (ESPR) United States $0.904B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.857B 7.65
Aquestive Therapeutics (AQST) United States $0.750B 0.00
KalVista Pharmaceuticals (KALV) United States $0.741B 0.00
ProKidney (PROK) United States $0.740B 0.00
Organogenesis (ORGO) United States $0.633B 0.00
Lexeo Therapeutics (LXEO) United States $0.632B 0.00
Bioventus (BVS) United States $0.627B 12.83
4D Molecular Therapeutics (FDMT) United States $0.611B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.607B 14.35
Elite Pharmaceuticals (ELTP) United States $0.569B 0.00
Altimmune (ALT) United States $0.533B 0.00
Zevra Therapeutics (ZVRA) United States $0.491B 0.00
Lyell Immunopharma (LYEL) United States $0.473B 0.00
Siga Technologies (SIGA) United States $0.447B 6.12
Akebia Therapeutics (AKBA) United States $0.417B 0.00
USANA Health Sciences (USNA) United States $0.369B 10.31
Nature's Sunshine Products (NATR) United States $0.369B 21.98
Galectin Therapeutics (GALT) United States $0.367B 0.00
Avalo Therapeutics (AVTX) United States $0.308B 0.00
Aclaris Therapeutics (ACRS) United States $0.301B 0.00
Silence Therapeutics (SLN) United Kingdom $0.299B 0.00
Relmada Therapeutics (RLMD) United States $0.298B 0.00
Aldeyra Therapeutics (ALDX) United States $0.293B 0.00
Larimar Therapeutics (LRMR) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.286B 0.00
OmniAb (OABI) United States $0.271B 0.00
Fractyl Health (GUTS) United States $0.263B 0.00
Protara Therapeutics (TARA) United States $0.262B 0.00
Achieve Life Sciences (ACHV) Canada $0.260B 0.00
Heron Therapeutics (HRTX) United States $0.233B 0.00
AleAnna (ANNA) United States $0.218B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.209B 0.00
Journey Medical (DERM) United States $0.209B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
MediWound (MDWD) Israel $0.196B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.187B 0.00
Innate Pharma SA (IPHYF) France $0.167B 0.00
China SXT Pharmaceuticals (SXTC) China $0.165B 0.00
Incannex Healthcare (IXHL) Australia $0.155B 0.00
Cassava Sciences (SAVA) United States $0.150B 0.00
Surrozen (SRZN) United States $0.135B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Gain Therapeutics (GANX) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.108B 0.00
Avita Medical (RCEL) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.102B 0.00
Context Therapeutics (CNTX) United States $0.100B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Karyopharm Therapeutics (KPTI) United States $0.093B 0.00
VAXART, INC (VXRT) United States $0.087B 0.00
Prelude Therapeutics (PRLD) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.083B 29.95
Plus Therapeutics (PSTV) United States $0.082B 0.00
Assertio Holdings (ASRT) United States $0.075B 0.00
Acrivon Therapeutics (ACRV) United States $0.072B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.068B 0.00
NRx Pharmaceuticals (NRXP) United States $0.068B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Lite Strategy (LITS) United States $0.065B 0.00
Rafael Holdings (RFL) United States $0.065B 0.00
PolyPid (PYPD) Israel $0.063B 0.00
Talphera (TLPH) United States $0.061B 0.00
Arch Biopartners (ACHFF) Canada $0.060B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Korro Bio (KRRO) United States $0.057B 0.00
Nutriband (NTRB) United States $0.055B 0.00
BioNxt Solutions (BNXTF) Canada $0.053B 0.00
Wellgistics Health (WGRX) United States $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Jupiter Neurosciences (JUNS) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.035B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.034B 28.50
FibroGen (FGEN) United States $0.033B 0.00
Inotiv (NOTV) United States $0.032B 0.00
Vyome Holdings (HIND) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Liminatus Pharma (LIMN) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Mangoceuticals (MGRX) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
Heatwurx (PCSA) United States $0.015B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.015B 0.00
Tempest Therapeutics (TPST) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
ProPhase Labs (PRPH) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 17.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00